Location United States, North America Gender Male
Investor Type
LinkedIn View on LinkedIn
Michael Rome is a Managing Director at Foresite Capital.
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
obfuscated obfuscation | RayThera | Foresite Capital | Series A - RayThera | obfuscated obfuscation | |
obfuscated obfuscation | Alumis | Foresite Capital | Series C - Alumis | obfuscated obfuscation | |
obfuscated obfuscation | Remix Therapeutics | Foresite Capital | Venture Round - Remix Therapeutics | obfuscated obfuscation | |
obfuscated obfuscation | CG Oncology | Foresite Capital | Series F - CG Oncology | obfuscated obfuscation | |
obfuscated obfuscation | Remix Therapeutics | Foresite Capital | Series B - Remix Therapeutics | obfuscated obfuscation | |
obfuscated obfuscation | XinThera | Foresite Capital | Series B - XinThera | obfuscated obfuscation | |
obfuscated obfuscation | Alumis | Foresite Capital | Series A - Alumis | obfuscated obfuscation | |
obfuscated obfuscation | Theseus Pharmaceuticals | Foresite Capital | Series B - Theseus Pharmaceuticals | obfuscated obfuscation | |
obfuscated obfuscation | Remix Therapeutics | Foresite Capital | Series A - Remix Therapeutics | obfuscated obfuscation | |
obfuscated obfuscation | Kinnate Biopharma | Foresite Capital | Series C - Kinnate Biopharma | obfuscated obfuscation |